Detection of C677T mutation in methylenetetrahydrofolate reductase gene by denaturing high performance liquid chromatography

被引:4
作者
Fang, NH [1 ]
Lin, L [1 ]
Ren, JC [1 ]
Wu, D [1 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Chem, Shanghai 200240, Peoples R China
关键词
methylenetetrahydrofolate reductase (MTHFR); mutation detection; denaturing high-performance chromatography; (DHPLC);
D O I
10.1002/bmc.364
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In this paper, we described an assay for the detection of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene using denaturing high-performance liquid chromatography (DHPLC). The conditions for DHPLC analysis were systematically investigated based on a general HPLC instrument (Prostar VARIAN). A 225 by DNA fragment covering the 677 site of MTHFR gene was amplified by PCR technology using the purified DNA from whole blood or whole blood as template DNA. PCR products were directly injected without the need for purification. The C677T mutation could be clearly distinguished by DHPLC technology. Our data demonstrated that DHPLC was a powerful and alternative tool for detection of genetic variants and single-nucleotide polymorphisms to electrophoresis technology. Copyright (C) 2004 John Wiley Sons, Ltd.
引用
收藏
页码:625 / 629
页数:5
相关论文
共 27 条
[1]  
ANDREA LA, 2002, CLIN CHIM ACTA, V18, P139
[2]   Interpreting epidemiological research:: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1 [J].
Eng, C ;
Brody, LC ;
Wagner, TMU ;
Devilee, P ;
Vijg, J ;
Szabo, C ;
Tavtigian, SV ;
Nathanson, KL ;
Ostrander, E ;
Frank, TS .
JOURNAL OF MEDICAL GENETICS, 2001, 38 (12) :824-833
[3]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[4]   Homocysteine and risk of premature coronary heart disease - Evidence for a common gene mutation [J].
Gallagher, PM ;
Meleady, R ;
Shields, DC ;
Tan, KS ;
McMaster, D ;
Rozen, R ;
Evans, A ;
Graham, IM ;
Whitehead, AS .
CIRCULATION, 1996, 94 (09) :2154-2158
[5]   Analysis and purification of nucleic acids by ion-pair reversed-phase high-performance liquid chromatography [J].
Hecker, KH ;
Green, SM ;
Kobayashi, K .
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 2000, 46 (1-2) :83-93
[6]   Optimization of cloning efficacy by pre-cloning DNA fragment analysis [J].
Hecker, KH ;
Turpie, B ;
Kuklin, A .
BIOTECHNIQUES, 1999, 26 (02) :216-+
[7]   Molecular variant of 5,10-methylenetetrahydrofolate reductase risk factor of ischemic heart disease in the Japanese population [J].
Izumi, M ;
Iwai, N ;
Ohmichi, N ;
Nakamura, Y ;
Shimoike, H ;
Kinoshita, M .
ATHEROSCLEROSIS, 1996, 121 (02) :293-294
[8]   Homocyst(e)ine levels in patients on phenytoin therapy [J].
James, GK ;
Jones, MW ;
Pudek, MR .
CLINICAL BIOCHEMISTRY, 1997, 30 (08) :647-649
[9]   Thermolabile methylenetetrahydrofolate reductase in coronary artery disease [J].
Kluijtmans, LAJ ;
Kastelein, JJP ;
Lindemans, J ;
Boers, GHJ ;
Heil, SG ;
Bruschke, AVG ;
Jukema, JW ;
vandenHeuvel, LPWJ ;
Trijbels, FJM ;
Boerma, GJM ;
Verheugt, FWA ;
Willems, F ;
Blom, HJ .
CIRCULATION, 1997, 96 (08) :2573-2577
[10]  
Kluijtmans LAJ, 1996, AM J HUM GENET, V58, P35